Conditions: Irritable Bowel Syndrome With Constipation
Keywords: IBS
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 805
Healthy volunteers: no

Brief summary:
The purpose of this study is to determine the safety and efficacy of linaclotide administered to patients with Irritable Bowel Syndrome with Constipation (IBS-C).

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: Linaclotide or Matching Placebo
Intervention descriptions: intervention 1: Linaclotide or Matching Placebo, administered orally, once daily, for the duration of the trial

Protocol document: